Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 41

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Genetics of drug‐induced liver injury: Current knowledge and future prospects

Daly, Ann K. · 2023 · Clinical and Translational Science

Abstract

Idiosyncratic drug‐induced liver injury (DILI) remains an important clinical problem, both during drug development and the prescription of a range of licensed drugs. Although rare, the consequences are serious. Ongoing studies on genetic risk factors for DILI, especially genomewide association studies, have resulted in the identification of a number of genetic risk factors, including particular HLA alleles and a few non‐HLA genes, both immune‐related and metabolic. Some non‐HLA associations, such as N‐acetyltransferase 2 in isoniazid DILI and interferon regulatory factor 6 in interferon‐beta DILI are likely to be drug‐specific due to the role of the associated gene, but there is also evidence for polygenic susceptibility involving pathways such as oxidative and endoplasmic reticulum stress and mitochondrial function for DILI induced by multiple drugs. Increased knowledge of genetic risk factors should assist in better understanding underlying DILI mechanisms and help improve methods for identifying hepatotoxic drugs early in development. HLA allele‐specific T cell proliferation together with in silico prediction of drug binding to specific HLA proteins have confirmed genetic findings for certain common causes of DILI. However, studies in hepatocytes exposed to high drug concentrations suggest toxicity that is not dependent on genotype also occurs. It seems likely that susceptibility to DILI involves several genetic risk factors combining with other factors that affect drug levels. Despite recent progress in detecting genetic risk factors for DILI, low positive predictive values mean that general implementation of genotyping prior to prescription of potentially hepatotoxic drugs is not useful currently.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cts.13424

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. 10.1007/s40264-021-01109-4 · DOI
  2. 10.1111/liv.15378 · DOI · Paper page
  3. 10.1016/S0016-5085(99)70404-X · DOI · Paper page
  4. 10.1038/ng.379 · DOI · Paper page
  5. 10.1038/tpj.2008.4 · DOI
  6. 10.1053/j.gastro.2016.12.016 · DOI · Paper page
  7. 10.1053/j.gastro.2019.01.034 · DOI · Paper page
  8. Nicoletti P, 2019, Discovery of ERAP2 gene expression as a risk factor for drug‐induced liver injury due to amoxicillin‐clavulanic acid, Hepatology, 70, 137A
  9. 10.1097/MOG.0000000000000822 · DOI
  10. 10.1038/s41588-018-0168-y · DOI
  11. 10.1038/s41591-020-1023-0 · DOI · Paper page
  12. 10.1128/AAC.02692-18 · DOI
  13. 10.1053/jhep.2002.32102 · DOI · Paper page
  14. 10.1002/cpt.2100 · DOI · Paper page
  15. 10.3389/fgene.2021.652704 · DOI
  16. 10.1007/s00228-012-1429-9 · DOI · Paper page
  17. 10.1124/dmd.118.082719 · DOI
  18. 10.1002/cpt.2343 · doi:10.1002/cpt.2343
  19. 10.1002/hep.26077 · DOI · Paper page
  20. 10.1002/hep.27912 · DOI
  21. 10.1021/acs.chemrestox.8b00163 · DOI
  22. 10.1021/acs.chemrestox.6b00400 · doi:10.1021/acs.chemrestox.6b00400
  23. 10.1016/j.jhep.2017.03.010 · DOI · Paper page
  24. 10.1016/j.freeradbiomed.2017.11.017 · DOI
  25. 10.1016/j.fct.2021.112664 · DOI
  26. 10.1016/j.yamp.2020.07.010 · DOI

Cited by

See all 41

Metadata

Authors
Daly, A. K.
Affiliations
Translational & Clinical Research Institute Newcastle University Newcastle upon Tyne UK
Venue
Clinical and Translational Science
Publisher
Wiley
Published
2022-10-04
Volume
16
Issue
1
Pages
37-42
ISSN
  • 1752-8054
  • 1752-8062
Cited by
41
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.